NEWPORT BEACH, Calif., January 16, 2017 –  CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar with TRiNDS, a new specialized contract research organization for neuromuscular diseases, on January 24 at 1 p.m. EST/10 a.m. PST. The webinar is an opportunity for the Duchenne community […]
NEWPORT BEACH, Calif., January 10, 2017 –  CureDuchenne announced today that BioMarinPharmaceutical Inc. has transferred its Duchenne natural history database to CureDuchenne, the venture philanthropy not-for-profit organization that is leading Duchenne research. CureDuchenne will house and maintain BioMarin’s natural history database, and will facilitate sharing of currently warehoused data and collaborate with other institutions as well, […]
NEWPORT BEACH, Calif., Dec. 19, 2016 –  CureDuchenne Ventures, LLC, a company that funds research to find a cure for Duchenne muscular dystrophy, announced today that they invested inTRiNDS, LLC, a new contract research organization born from the Cooperative International Neuromuscular Research Group (CINRG) academic consortium. Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS) provides specialized […]
NEWPORT BEACH, Calif., December 1, 2016 – The date for the highly anticipated 2017 Napa in Newport Wine Auction has been set for March 4 at the Ritz-Carlton, Laguna Niguel. Southern California’s premier annual wine event, Napa in Newport, unites 30 renowned vintners and wine enthusiasts to help find a cure for Duchenne muscular dystrophy, […]
Newport Beach, CA Nov. 28, 2016 — It has taken decades, millions of research dollars, heartache and hopefulness to reach a critical milestone of the first FDA approved pharmaceutical treatment for those with Duchenne muscular dystrophy. This first treatment will only help 13% of those who battle with this genetic disease, and CureDuchenne, a national […]
NEWPORT BEACH, CA. October 25, 2016 – CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host an informational webinar on November 1, 2016 at 2:00 p.m. ET/11:00 a.m. PT to update the community on Marathon Pharmaceutical’s efforts to secure FDA approval for deflazacort. If deflazacort is approved […]
Consortium Working Together to Bring Quality of Life Treatments to the Duchenne Community NEWPORT BEACH, Calif., October 25, 2016 – The next wave in tackling Duchenne Muscular Dystrophy is getting a boost from a collaboration of nonprofit organizations, biopharmaceutical companies and noted clinicians who have joined together to advance the progress of drug development and […]
NEWPORT BEACH, Calif., October 7, 2016: CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar with Dr. Kevin Flanigan from Nationwide Children’s Hospital on October 12 at 4 p.m. ET/ 1 p.m. PT. The webinar is an opportunity for the Duchenne community to learn the […]
NEWPORT BEACH, CA. October 6, 2016 – CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar with Sarepta Therapeutics, Inc. (NASDAQ: SRPT) on October 11 at 1 p.m. ET/10 a.m. PT to provide the Duchenne community an overview of Sarepta’s patient support program, SareptAssist. The […]
1 2 3 4 5 13

Monthly Archives

Are you looking for a physical therapist who is specially trained to care for your loved one with Duchenne?

Find CureDuchenne Cares Certified PTs across the nation

Are you a physical therapist?

Learn more about the CureDuchenne Cares Physical Therapy certification program and its benefits.

CLICK HERE